The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1
Abstract
Lynch syndrome patients are susceptible to colorectal and endometrial cancers owing to inactivating germline mutations in mismatch repair genes, including MSH2 (ref. 1). Here we describe patients from Dutch and Chinese families with MSH2-deficient tumors carrying heterozygous germline deletions of the last exons of TACSTD1, a gene directly upstream of MSH2 encoding Ep-CAM. Due to these deletions, transcription of TACSTD1 extends into MSH2. The MSH2 promoter in cis with the deletion is methylated in Ep-CAM positive but not in Ep-CAM negative normal tissues, thus revealing a correlation between activity of the mutated TACSTD1 allele and epigenetic inactivation of the corresponding MSH2 allele. Gene silencing by transcriptional read-through of a neighboring gene in either sense, as demonstrated here, or antisense direction, could represent a general mutational mechanism. Depending on the expression pattern of the neighboring gene that lacks its normal polyadenylation signal, this may cause either generalized or mosaic patterns of epigenetic inactivation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In these cases, the abnormal DNA methylation of the gene under investigation was linked to a mutation in a neighboring gene that removed the transcription termination signal (Fig. 1b).”
From A critical view on transgenerational epigenetic inheritance in humans (2018) · cites this paper as [16]
In the citing paper
“Several studies14–16 including a recent study by Guéant et al.18 in this journal, have reported the co-segregation of an abnormal DNA methylation pattern (called “epimutation”) with a rare disease in two or more generations of certain families.”
From A critical view on transgenerational epigenetic inheritance in humans (2018) · cites this paper as [16]
In the citing paper
“Most cases of segregation of abnormal DNA methylation patterns in families with rare diseases, however, turned out to be caused by an underlying genetic variant14–16 (see below).”
From A critical view on transgenerational epigenetic inheritance in humans (2018) · cites this paper as [16]
In the citing paper
“As a consequence, transcription from this gene extended into the gene under investigation, causing abnormal promoter methylation and gene silencing.”
From A critical view on transgenerational epigenetic inheritance in humans (2018) · cites this paper as [16]
Citations
Cites
Beighton, P., & Beighton, G. (1997) · Springer eBooks · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,165
Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,240
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyák, K., Graff, J. R., Ahuja, N., Issa, J. J., Markowitz, S. D., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
Kane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476
Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA
Yu, W., Gius, D. R., Onyango, P. O., Muldoon‐Jacobs, K., Karp, J. E., Feinberg, A. P., & Cui, H. (2008) · Nature · doi:10.1038/nature06468 · Cited by 801
Tufarelli, C., Stanley, J. A. S., Garrick, D., Sharpe, J. A., Ayyub, H., Wood, W. G., & Higgs, D. R. (2003) · Nature Genetics · doi:10.1038/ng1157 · Cited by 547
Germline epimutation of MLH1 in individuals with multiple cancers
Suter, C. M., Martin, D. I. K., & Ward, R. L. (2004) · Nature Genetics · doi:10.1038/ng1342 · Cited by 475
Inheritance of a Cancer-Associated MLH1 Germ-Line Epimutation
Hitchins, M. P., Wong, J. J. L., Suthers, G., Suter, C. M., Martin, D. I. K., Hawkins, N. J., & Ward, R. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064522 · Cited by 409
Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer
Chan, T. L., Yuen, S. T., Kong, C. K., Chan, Y. W., Chan, A. S., Ng, W. F., Tsui, W. Y., Lo, M. W., Tam, W. Y., Li, V. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1866 · Cited by 324
Self-citationNew perspectives on connecting messenger RNA 3′ end formation to transcription
Proudfoot, N. J. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.03.007 · Cited by 285
Flagged first, then by citations
Cited by
Sorted by citations
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Landon, M., Saam, J. R., Brown, K. L., Moyes, K., Evans, B. A., & WENSTRUP, R. J. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,943
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662
Hereditary and Familial Colon Cancer
Jasperson, K. W., Tuohy, T. M. F., Neklason, D. W., & Burt, R. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.054 · Cited by 1,370
Microsatellite Instability in Colorectal Cancer-the Stable Evidence
Vilar, E., & Gruber, S. B. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.237 · Cited by 1,063
Luchini, C., Bibeau, F., Ligtenberg, M. J. L., Singh, N., Nottegar, A., Bosse, T., Miller, R. E., Riaz, N., Douillard, J.-Y., André, F., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz116 · Cited by 1,057
Self-citationMicrosatellite Instability as a Biomarker for PD-1 Blockade
Dudley, J. C., Lin, M., Le, D. T., & Eshleman, J. R. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1678 · Cited by 941
Interplay between the Cancer Genome and Epigenome
Shen, H., & Laird, P. W. (2013) · Cell · doi:10.1016/j.cell.2013.03.008 · Cited by 949
Milestones of Lynch syndrome: 1895–2015
Lynch, H. T., Snyder, C., Shaw, T. G., Heinen, C. D., & Hitchins, M. P. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3878 · Cited by 808
Vasen, H. F. A., Blanco, I., Aktan-Collan, K., Gopie, J. P., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Burn, J., Capella, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304356 · Cited by 746
Gene regulation by the act of long non-coding RNA transcription
Kornienko, A. E., Guenzl, P. M., Barlow, D. P., & Pauler, F. M. (2013) · BMC Biology · doi:10.1186/1741-7007-11-59 · Cited by 724
Understanding transgenerational epigenetic inheritance via the gametes in mammals
Daxinger, L., & Whitelaw, E. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3188 · Cited by 728
Zhao, P., Li, L., Jiang, X., & Li, Q. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0738-1 · Cited by 682
A molecular portrait of microsatellite instability across multiple cancers
Cortés‐Ciriano, I., Lee, S., Park, W., Kim, T., & Park, P. J. (2017) · Nature Communications · doi:10.1038/ncomms15180 · Cited by 669
Early‐onset colorectal cancer in young individuals
Mauri, G., Bianchi, A. S., Russo, A. G., Marsoni, S., Bardelli, A., & Siena, S. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12417 · Cited by 653
Genetic and biological hallmarks of colorectal cancerPreprint
Li, J., Ma, X., Chakravarti, D., Shalapour, S., & DePinho, R. A. (2021) · Genes & Development · doi:10.1101/gad.348226.120 · Cited by 617
Baretti, M., & Le, D. T. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.04.004 · Cited by 574
Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer
Win, A. K., Jenkins, M. A., Dowty, J. G., Antoniou, A. C., Lee, A., Giles, G. G., Buchanan, D. D., Clendenning, M., Rosty, C., Ahnen, D. J., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0693 · Cited by 525
DNA Methyltransferases, DNA Damage Repair, and Cancer
Jin, B., & Robertson, K. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9967-2_1 · Cited by 545
Season of Conception in Rural Gambia Affects DNA Methylation at Putative Human Metastable Epialleles
Waterland, R. A., Kellermayer, R., Laritsky, E., Rayco‐Solon, P., Harris, R. A., Travisano, M., Zhang, W., Torskaya, M. S., Zhang, J., Shen, L., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001252 · Cited by 465
Taby, R. F., & Issa, J. J. (2010) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20085 · Cited by 429
Haraldsdóttir, S., Hampel, H., Tomšič, J., Frankel, W. L., Pearlman, R., de la Chapelle, A., & Pritchard, C. C. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.041 · Cited by 377
Stoffel, E. M., Mangu, P. B., Gruber, S. B., Hamilton, S. R., Kalady, M. F., Lau, M. W. Y., Lu, K. H., Roach, N., & Limburg, P. J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.1322 · Cited by 374
A critical view on transgenerational epigenetic inheritance in humans
Horsthemke, B. (2018) · Nature Communications · doi:10.1038/s41467-018-05445-5 · Cited by 349
The future of epigenetic therapy in solid tumours—lessons from the past
Azad, N. S., Zahnow, C. A., Rudin, C. M., & Baylin, S. B. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.42 · Cited by 346
LaDuca, H., Stuenkel, A. J., Dolinsky, J. S., Keiles, S. B., Tandy, S., Pesaran, T. F., Chen, E. Y., Gau, C., Palmaer, E., Shoaepour, K., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.40 · Cited by 334
Riley, B. D., Culver, J. O., Skrzynia, C., Senter, L. A., Peters, J. A., Costalas, J. W., Callif‐Daley, F., Grumet, S., Hunt, K. S., Nagy, R. S., et al. (2011) · Journal of Genetic Counseling · doi:10.1007/s10897-011-9462-x · Cited by 330
Mensenkamp, A. R., Vogelaar, I. P., van Zelst–Stams, W. A. G., Goossens, M., Ouchene, H., Hendriks-Cornelissen, S. J. B., Kwint, M. P., Hoogerbrugge, N., Nagtegaal, I. D., & Ligtenberg, M. J. L. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.12.002 · Cited by 329
Self-citationEpCAM in carcinogenesis: the good, the bad or the ugly
van der Gun, B. T. F., Melchers, L. J., Ruiters, M. H. J., de Leij, L. F. M. H., McLaughlin, P. M., & Rots, M. G. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq187 · Cited by 322
Cortessis, V. K., Thomas, D. C., Levine, A. J., Breton, C. V., Mack, T. M., Siegmund, K. D., Haile, R. W., & Laird, P. W. (2012) · Human Genetics · doi:10.1007/s00439-012-1189-8 · Cited by 319
Molecular pathways in colorectal cancer
Al‐Sohaily, S., Biankin, A. V., Leong, R. W. L., Kohonen‐Corish, M. R. J., & Warusavitarne, J. H. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07200.x · Cited by 318
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
Kempers, M. J. E., Kuiper, R. P., Ockeloen, C. W., Chappuis, P. O., Hutter, P., Rahner, N., Schackert, H. K., Steinke, V., Holinski‐Feder, E., Morak, M., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70265-5 · Cited by 293
Self-citationSpaander, M. C. W., Zauber, A. G., Syngal, S., Blaser, M. J., Sung, J. J. �., You, Y. N., & Kuipers, E. J. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00432-7 · Cited by 319
EpCAM: Structure and function in health and disease
Schnell, U., Cirulli, V., & Giepmans, B. N. G. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.04.018 · Cited by 316
Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade
Lee, V., Murphy, A. G., Le, D. T., & Diaz, L. A. (2016) · The Oncologist · doi:10.1634/theoncologist.2016-0046 · Cited by 283
Lynch Syndrome–Associated Colorectal Cancer
Sinicrope, F. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1714533 · Cited by 291
Genetics, Cytogenetics, and Epigenetics of Colorectal Cancer
Migliore, L., Migheli, F., Spisni, R., & Coppedè, F. (2011) · BioMed Research International · doi:10.1155/2011/792362 · Cited by 277
Epigenetics of Colorectal Cancer
Goel, A., & Boland, C. R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.032 · Cited by 280
Genomic Imprinting: A Mammalian Epigenetic Discovery Model
Barlow, D. P. (2011) · Annual Review of Genetics · doi:10.1146/annurev-genet-110410-132459 · Cited by 272
McAlpine, J. N., León‐Castillo, A., & Bosse, T. (2018) · The Journal of Pathology · doi:10.1002/path.5034 · Cited by 256
Epigenetics and Colorectal Cancer Pathogenesis
Bardhan, K., & Liu, K. (2013) · Cancers · doi:10.3390/cancers5020676 · Cited by 266
The molecular genetics of colorectal cancer
Ewing, I., Hurley, J. J., Josephides, E., & Millar, A. (2013) · Frontline Gastroenterology · doi:10.1136/flgastro-2013-100329 · Cited by 250
Molecular basis of α-thalassemia
Farashi, S., & Harteveld, C. L. (2018) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2017.09.004 · Cited by 227
Microsatellite instability: an update
Yamamoto, H., & Imai, K. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1474-0 · Cited by 247
Tabori, U. Y., Hansford, J. R., Achatz, M. I., Kratz, C. P., Plon, S. E., Frébourg, T., & Brugières, L. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0574 · Cited by 226
Risk of Cancer in Cases of Suspected Lynch Syndrome Without Germline Mutation
Soler, M. R., Pérez–Carbonell, L., Guarinós, C., Zapater, P., Castillejo, A., Barberá, V. M., Juárez, M., Bessa, X., Xicola, R. M., Clofent, J., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.044 · Cited by 224
Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome
Niessen, R. C., Hofstra, R. M. W., Westers, H., Ligtenberg, M. J. L., Kooi, K. A., Jager, P. O. J., de Groote, M. L., Dijkhuizen, T., Olderode-Berends, M. J. W., Hollema, H., et al. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20678 · Cited by 223
Self-citationColorectal Cancer Epigenetics: Complex Simplicity
van Engeland, M., Derks, S., Smits, K. M., Meijer, G. A., & Herman, J. G. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.2319 · Cited by 206
Biology and clinical relevance of EpCAM
Keller, L., Werner, S., & Pantel, K. (2019) · Cell Stress · doi:10.15698/cst2019.06.188 · Cited by 196
Scrutinizing the epigenetics revolution
Meloni, M., & Testa, G. (2014) · BioSocieties · doi:10.1057/biosoc.2014.22 · Cited by 189
Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored
Li, S. K. H., & Martín, A. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.02.003 · Cited by 199
Pérez–Carbonell, L., Ruíz-Ponte, C., Guarinós, C., Alenda, C., Payá, A., Brea‐Fernández, A., Egoavil, C. M., Castillejo, A., Barberá, V. M., Bessa, X., et al. (2011) · Gut · doi:10.1136/gutjnl-2011-300041 · Cited by 196
Milekic, M. H., Xin, Y., O’Donnell, A., Kumar, K. K., Bradley-Moore, M., Malaspina, D., Moore, H., Brunner, D., Ge, Y., Edwards, J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.84 · Cited by 190
Deficient mismatch repair: Read all about it (Review)
Richman, S. D. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3119 · Cited by 196
Hitchins, M. P., Rapkins, R. W., Kwok, C., Srivastava, S., Wong, J. J. L., Khachigian, L. M., Polly, P., Goldblatt, J., & Ward, R. L. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.07.003 · Cited by 182
Lynch Syndrome Genetics and Clinical Implications
Peltomäki, P., Nyström, M., Mecklin, J., & Seppälä, T. T. (2023) · Gastroenterology · doi:10.1053/j.gastro.2022.08.058 · Cited by 192
Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study
Kloor, M., Huth, C., Voigt, A. Y., Benner, A., Schirmacher, P., Doeberitz, M. V. K., & Bläker, H. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70109-2 · Cited by 175
Pathology and genetics of hereditary colorectal cancer
Ma, H., Brosens, L. A. A., Offerhaus, G. J. A., Giardiello, F. M., de Leng, W. W. J., & Montgomery, E. A. (2017) · Pathology · doi:10.1016/j.pathol.2017.09.004 · Cited by 187
Eso, Y., Shimizu, T., Takeda, H., Takai, A., & Marusawa, H. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01620-7 · Cited by 181
Molecular pathology of Lynch syndrome
Cerretelli, G., Ager, A., Arends, M. J., & Frayling, I. M. (2020) · The Journal of Pathology · doi:10.1002/path.5422 · Cited by 179
Update on Lynch syndrome genomics
Peltomäki, P. (2016) · Familial Cancer · doi:10.1007/s10689-016-9882-8 · Cited by 170
Jeziorska, D. M., Murray, R. J. S., De Gobbi, M., Gaentzsch, R., Garrick, D., Ayyub, H., Chen, T., Li, E., Telenius, J., Lynch, M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703087114 · Cited by 166
Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines
Balmañà, J., Balaguer, F., Cervantes, A. M. R., & Arnold, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt209 · Cited by 165
Environmental epigenetic inheritance through gametes and implications for human reproduction
Wei, Y., Schatten, H., & Sun, Q. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu061 · Cited by 162
Epigenetic inheritance in mammals: Evidence for the impact of adverse environmental effects
Franklin, T. B., & Mansuy, I. M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.012 · Cited by 153
Hitchins, M. P., & Ward, R. L. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.068122 · Cited by 152
Recurrence and variability of germline EPCAM deletions in Lynch syndrome
Kuiper, R. P., Vissers, L. E. L. M., Venkatachalam, R., Bodmer, D., Hoenselaar, E., Goossens, M., Haufe, A., Kamping, E. J., Niessen, R. C., Hogervorst, F. B. L., et al. (2011) · Human Mutation · doi:10.1002/humu.21446 · Cited by 156
Self-citationGermline deletions in the EPCAM gene as a cause of Lynch syndrome – literature review
Tutlewska, K., Lubiński, J., & Kurzawski, G. (2013) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-11-9 · Cited by 154
Mutational signatures of DNA mismatch repair deficiency in C. elegans and human cancersPreprint
Meier, B., Volkova, N. V., Hong, Y., Schofield, P. G., Campbell, P. J., Gerstung, M., & Gartner, A. (2018) · Genome Research · doi:10.1101/gr.226845.117 · Cited by 158
Evans, D. G., Astley, S., Stavrinos, P., Harkness, E. F., Donnelly, L. S., Dawe, S., Jacob, I., Harvie, M., Cuzick, J. M., Brentnall, A. R., et al. (2016) · Programme Grants for Applied Research · doi:10.3310/pgfar04110 · Cited by 153
EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients
Ligtenberg, M. J. L., Kuiper, R. P., van Kessel, A. G., & Hoogerbrugge, N. (2012) · Familial Cancer · doi:10.1007/s10689-012-9591-x · Cited by 150
Self-citationQuiñonez-Silva, G., Dávalos-Salas, M., Targa, F. R., Ostrosky‐Wegman, P., Arenas-Aranda, D. J., & Benı́tez-Bribiesca, L. (2016) · Clinical Epigenetics · doi:10.1186/s13148-015-0167-0 · Cited by 148
Singh, M. P., Rai, S., Pandey, A., Singh, N. K., & Srivastava, S. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.10.013 · Cited by 167
Somatic aberrations of mismatch repair genes as a cause of microsatellite‐unstable cancers
Geurts-Giele, W. R. R., Leenen, C. H., Dubbink, H. J., Meijssen, I. C., Post, E., Sleddens, H. F. B. M., Kuipers, E. J., Goverde, A., van den Ouweland, A. M., van Lier, M. G., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4419 · Cited by 148
Gene body methylation in cancer: molecular mechanisms and clinical applications
Wang, Q., Xiong, F., Wu, G., Liu, W., Chen, J., Wang, B., & Chen, Y. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01382-9 · Cited by 150
The Molecular Basis of -Thalassemia
Higgs, D. R. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011718 · Cited by 126
Epigenome-Wide Association Studies (EWAS): Past, Present, and Future
Flanagan, J. M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1804-1_3 · Cited by 145
Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine
Nebot-Bral, L., Brandão, D., Verlingue, L., Rouleau, É., Caron, O., Despras, E., Dakdouki, Y. E., Champiat, S., Aoufouchi, S., Leary, A. F., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.07.026 · Cited by 144
Gatalica, Z., Vranic, S., Xiu, J., Swensen, J., & Reddy, S. (2016) · Familial Cancer · doi:10.1007/s10689-016-9884-6 · Cited by 141
Lynch Syndrome: An Updated Review
Sehgal, R., Sheahan, K. D., O’Connell, P. R., Hanly, A. M., Martin, S., & Winter, D. C. (2014) · Genes · doi:10.3390/genes5030497 · Cited by 140
Microsatellite Instability and Colorectal Cancer
Geiersbach, K. B., & Samowitz, W. S. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0035-ra · Cited by 151
Risk of Prostate Cancer in Lynch Syndrome: A Systematic Review and Meta-analysis
Ryan, S., Jenkins, M. A., & Win, A. K. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1165 · Cited by 140
Precancerous colorectal lesions
Conteduca, V., Sansonno, D. E., Russi, S., & Dammacco, F. (1943) · International Journal of Oncology · doi:10.3892/ijo.2013.2041 · Cited by 138
Germline copy number variation and cancer risk
Kuiper, R. P., Ligtenberg, M. J. L., Hoogerbrugge, N., & van Kessel, A. G. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.03.005 · Cited by 141
Self-citationWeissman, S. M., Burt, R. W., Church, J. M., Erdman, S., Hampel, H., Holter, S., Jasperson, K. W., Kalady, M. F., Haidle, J. L., Lynch, H. T., et al. (2011) · Journal of Genetic Counseling · doi:10.1007/s10897-011-9465-7 · Cited by 132
Genomic insights into cancer-associated aberrant CpG island hypermethylation
Sproul, D., & Meehan, R. R. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/els063 · Cited by 135
Aronson, M. D., Colas, C., Shuen, A. Y., Hampel, H., Foulkes, W. D., Feldman, H. B., Goldberg, Y., Muleris, M., Schneider, K. W., McGee, R. B., et al. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107627 · Cited by 132
Clinical management of hereditary colorectal cancer syndromes
Vasen, H. F. A., Tomlinson, I. P. M., & Castells, A. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.229 · Cited by 131
Early-onset colorectal cancer: A sporadic or inherited disease?
Stigliano, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i35.12420 · Cited by 129
Diouf, B., Cheng, Q., Krynetskaia, N. F., Yang, W., Cheok, M., Pei, D., Fan, Y., Cheng, C., Krynetskiy, E. Y., Geng, H., et al. (2011) · Nature Medicine · doi:10.1038/nm.2430 · Cited by 129
Boland, C. R., & Lynch, H. T. (2013) · Familial Cancer · doi:10.1007/s10689-013-9637-8 · Cited by 145
Hansmann, T., Pliushch, G., Leubner, M., Kroll, P., Endt, D., Gehrig, A., Preisler-Adams, S., Wieacker, P. F., & Haaf, T. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds308 · Cited by 125
Dominguez–Valentin, M., Haupt, S., Seppälä, T. T., Sampson, J. R., Sunde, L., Bernstein, I., Jenkins, M. A., Engel, C., Aretz, S., Nielsen, M., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101909 · Cited by 126
Aberrant DNA Methylation in Colorectal Cancer: What Should We Target?
Tse, J. W. T., Jenkins, L. J., Chionh, F. J. M., & Mariadason, J. M. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.08.003 · Cited by 125
Constitutional epimutation as a mechanism for cancer causality and heritability?
Hitchins, M. P. (2015) · Nature reviews. Cancer · doi:10.1038/nrc4001 · Cited by 127
Somatic Hypermethylation of MSH2 Is a Frequent Event in Lynch Syndrome Colorectal Cancers
Nagasaka, T., Rhees, J., Kloor, M., Gebert, J. F., Naomoto, Y., Boland, C. R., & Goel, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3290 · Cited by 120
Molecular genetics of microsatellite-unstable colorectal cancer for pathologists
Chen, W., Swanson, B. J., & Frankel, W. L. (2017) · Diagnostic Pathology · doi:10.1186/s13000-017-0613-8 · Cited by 126
Ryan, É. J., Sheahan, K. D., Creavin, B., Mohan, H. M., & Winter, D. C. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.05.006 · Cited by 121
Differentiating Lynch-Like From Lynch Syndrome
Carethers, J. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.041 · Cited by 116
Metadata
- Authors
- Ligtenberg, M. J. L., Kuiper, R. P., Chan, T. L., Goossens, M., Hebeda, K. M., Voorendt, M., Lee, T. Y. H., Bodmer, D., Hoenselaar, E., Hendriks-Cornelissen, S. J. B., Tsui, W. Y., Kong, C. K., Brunner, H. G., van Kessel, A. G., Yuen, S. T., van Krieken, J. H. J. M., Leung, S. Y., & Hoogerbrugge, N.
- Affiliations
- Radboud University Medical Center (NL)
- Queen Mary Hospital (CN)
- Yan Chai Hospital (HK)
- Corresponding author
- Ligtenberg, Marjolijn J L
- Leung, Suet Yi
- ORCID
- Venue
- Nature Genetics
- Published
- 2008-12-21
- Volume
- 41
- Issue
- 1
- Pages
- 112-117
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1972254989
- Cited by
- 818
- References
- 25
- Citations by year
- 2026: 19 · 2025: 34 · 2024: 38 · 2023: 45 · 2022: 34 · 2021: 41 · 2020: 59 · 2019: 44 · 2018: 54 · 2017: 51 · 2016: 56 · 2015: 46 · 2014: 59 · 2013: 71 · 2012: 49
- FWCI
- 27.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- Lynch syndrome, MSH2, EpCAM, germline deletion, read-through transcription, epigenetic silencing, mismatch repair genes, colorectal cancer, endometrial cancer, polyadenylation signal, gene silencing
- MeSH terms
- Epithelial Cell Adhesion Molecule, Adolescent, Adult, Alleles, Antigens, Neoplasm, Base Sequence, China, Colorectal Neoplasms, Hereditary Nonpolyposis, Exons, Family, Female, Humans, Male, Middle Aged, Molecular Sequence Data, Netherlands, Pedigree, Promoter Regions, Genetic, Cell Adhesion Molecules, Open Reading Frames, Sequence Deletion, DNA Methylation, Inheritance Patterns, White People, Asian People, MutS Homolog 2 Protein, Microsatellite Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review